Modular Nucleic Acid Detection With Enzyme-DNA Nanostructures

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleic acid detection methods, such as PCR and LAMP, are costly, complex, and prone to false positives, requiring specialized equipment and trained personnel, limiting their accessibility and accuracy in decentralized settings.

Innovation Solution

An integrated circuit of enzyme-DNA nanostructures, comprising an adjustable recognition element and a sensitive universal signaling element, decouples target recognition and visual signal amplification, enabling rapid, visual, and modular detection of nucleic acids without the need for amplification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional PCR or LAMP methods are used for nucleic acid detection, then detection sensitivity is improved, but device complexity and cost increase

Engineering Contradiction:
Improvedetection sensitivityVSAvoidequipment complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The detection system is divided into separate functional modules: a recognition module containing sequence-specific DNA aptamers for target binding, and a signaling module containing enzyme-conjugated nanoparticles for signal amplification. This segmentation allows each module to be optimized independently and simplifies the overall system architecture, eliminating the need for complex thermal cyclers while maintaining high detection sensitivity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs universal signaling nanoparticles conjugated with enzymes (such as horseradish peroxidase or alkaline phosphatase) that can be used across multiple detection platforms and target types. These universal reagents replace the need for specialized equipment, enabling the same signaling system to detect various nucleic acid targets through different recognition aptamers, thereby reducing device complexity while maintaining sensitivity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If sequence-specific signaling probes are used to improve detection accuracy, then measurement precision is improved, but cost and device complexity increase

Engineering Contradiction:
Improvedetection accuracyVSAvoidimplementation complexity
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The DNA aptamers in the recognition module autonomously perform sequence-specific binding to target nucleic acids without requiring external control systems or complex instrumentation. The enzyme-conjugated nanoparticles automatically catalyze signal amplification upon aptamer binding, eliminating the need for trained personnel to operate complex equipment. This self-service mechanism maintains high detection accuracy while dramatically simplifying implementation.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent uses inexpensive, easily synthesized DNA aptamers and commercially available enzyme-conjugated nanoparticles as disposable reagents. These reagents can be prepared in standard laboratory settings without specialized equipment and do not require expensive instrumentation for operation. The simplicity of the reagent system reduces both manufacturing complexity and operational costs while maintaining high detection accuracy through sequence-specific recognition.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Measurement precision

If conventional nucleic acid amplification methods are used, then detection sensitivity is improved, but false positives increase

Engineering Contradiction:
Improvedetection sensitivityVSAvoidfalse positive rate
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent extracts the amplification step from the detection system and replaces it with direct target binding to DNA aptamers followed by enzyme-mediated signal amplification. By removing the amplification phase that is prone to false positives from primer-dimer formation, the system maintains high detection sensitivity through enzymatic signal amplification while eliminating the source of false positives associated with nucleic acid amplification methods.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The enzyme-conjugated nanoparticles serve as intermediaries that translate specific aptamer-target binding events into amplified visual signals. This intermediary mechanism allows direct detection of target-nucleic acid hybrids without amplification, maintaining reliability by avoiding false positives while achieving sensitivity through the catalytic activity of enzymes that generate detectable signal products from the binding event.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system provides a rapid, sensitive, and cost-effective method for nucleic acid detection, capable of visual signal enhancement and quantification by smartphones, suitable for decentralized settings and multiplexed assays.

Implementation Method 1

a DNA polymerase enzyme-specific DNA aptamer... target nucleic acid binding to the variable sequence region of the aptamer promotes the formation of a stable aptamer-DNA polymerase enzyme complex

Methodology Applied
Scientific EffectMolecular recognition and binding: Adsorption

Implementation Method 2

the activated DNA polymerase enzyme adds labelled oligonucleotides to the signaling nanostructure and the signal development reagents bind to the labelled oligonucleotides incorporated into the self-primed portion

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentUS12404542B2Visual and modular detection of nucleic acids with enzyme-assisted nanotechnology
Publication Date: 2025.09.02 NATIONAL UNIVERSITY OF SINGAPORE
  • US12404542B2 patent drawing
  • US12404542B2 patent drawing
  • US12404542B2 patent drawing

AI summary

The present invention provides methods and devices for specific detection of nucleic acids using an integrated circuit of two independent enzyme-DNA nanostructures—an easily adjustable recognition element and a sensitive universal signaling element—to decouple target recognition and visual signal amplification. The recognition element comprises a DNA polymerase enzyme, a DNA polymerase enzyme-specific DNA aptamer and an inverter oligonucleotide. In the presence of a target nucleic acid, the inverter oligonucleotide binds to the target nucleic acid and releases the DNA polymerase enzyme from inhibition by the DNA aptamer. The activated DNA polymerase enzyme is then contacted with a signaling nanostructure comprising a self-priming portion responsive to the DNA polymerase enzyme, in the presence of labelled dNTPs and signal development reagents, wherein the activated DNA polymerase enzyme would add the labelled dNTPs to the self-priming portion, followed by the binding of the signal development reagents to the labelled dNTPs.